VaccinesXpert

As últimas notícias médicas sobre vacinação e vacinas
Versão online

Bem Vindo(a) ,

Leia abaixo as últimas publicações das principais revistas cientificas especializadas em sua área de competência.

Vacinas para adultos

Acceptability of a COVID-19 Vaccine among Adults in the United States: How Many People Would Get Vaccinated?

Vaccine 2020; aop:10.1016/j.vaccine.2020.08.043 | Reiter, Paul L. et al.

Coronavirus disease 2019 (COVID-19) was declared a pandemic in March 2020. Several prophylactic vaccines against COVID-19 are currently in development, yet little is known about people’s acceptability of a COVID-19 vaccine. We conducted an online...

Ler mais

Upsurge of conjugate vaccine serotype 4 invasive pneumococcal disease clusters among adults experiencing homelessness in California, Colorado, and New Mexico

The Journal of infectious diseases 2021; 223(7): 1241-9 | Bernard Beall et al.

After 7-valent pneumococcal conjugate vaccine introduction in the US in 2000, invasive pneumococcal disease (IPD) due to serotype 4 greatly decreased in children and adults. Starting in 2013, serotype 4 IPD incidence increased among adults >18 years...

Ler mais

One-year decline of poliovirus antibodies following fractional-dose inactivated poliovirus vaccine

The Journal of infectious diseases 2021; 223(7): 1214-21 | Ali Faisal Saleem et al.

Fractional dose (1/5 of full intramuscular dose) of inactivated poliovirus-vaccine administered intradermally (fIPV) is used as IPV dose-sparing strategy. We compared the rate of decline of poliovirus antibodies (PVA) in recipients of either two doses...

Ler mais

Futuras vacinas e outros

Modelling the impact of 4CMenB and MenACWY meningococcal combined vaccination strategies including potential 4CMenB cross-protection: An application to England

Vaccine 2020; aop:10.1016/j.vaccine.2020.08.007 | Beck, Ekkehard et al.

Invasive meningococcal disease (IMD), an uncommon but severe disease, affects mainly infants, young children and adolescents. Meningococcal B (4CMenB) and ACWY (MenACWY) vaccines targeting IMD-causing serogroups B and A, C, W and Y, respectively are available...

Ler mais

Ao fazer o registo no serviço "VaccinesXpert", aceito que a GNM Healthcare Consulting France SAS utilize os dados inseridos aquando da minha inscrição com o objetivo de me fornecer um envio de informações semanal relacionadas com os seus serviços, em conformidade com a Política de confidencialidade.
Dispõe de um direito de acesso, retificação e supressão sobre os seus dados, que poderá exercer, enviando o seu pedido a dpo@gnmhealthcare.com. Poderá igualmente exercer o seu direito de oposição, anulando a sua subscrição, a qualquer momento, através de um clique sobre o link "Cancelar a inscrição".